rs375735354
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_001267550.2(TTN):c.3514C>A(p.Leu1172Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000595 in 1,613,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1GInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- early-onset myopathy with fatal cardiomyopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- TTN-related myopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- myopathy, myofibrillar, 9, with early respiratory failureInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics
- tibial muscular dystrophyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- autosomal recessive limb-girdle muscular dystrophy type 2JInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- hypertrophic cardiomyopathy 9Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive centronuclear myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- congenital myopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary skeletal muscle disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.3514C>A | p.Leu1172Ile | missense_variant | Exon 21 of 363 | ENST00000589042.5 | NP_001254479.2 | |
TTN | NM_133379.5 | c.3514C>A | p.Leu1172Ile | missense_variant | Exon 21 of 46 | ENST00000360870.10 | NP_596870.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.3514C>A | p.Leu1172Ile | missense_variant | Exon 21 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 | ||
TTN | ENST00000360870.10 | c.3514C>A | p.Leu1172Ile | missense_variant | Exon 21 of 46 | 5 | NM_133379.5 | ENSP00000354117.4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152168Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000359 AC: 9AN: 250974 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000602 AC: 88AN: 1461654Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727128 show subpopulations
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74334 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
- -
- -
not specified Uncertain:2Benign:1
Variant summary: TTN c.3514C>A (p.Leu1172Ile) results in a conservative amino acid change located in the Z-disk region of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 250974 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.3514C>A has been reported in the literature in at least one individual affected with childhood onset myopathy attributed to pathogenic variants in the NEB gene (e.g., Scoto_2013). This report does not provide unequivocal conclusions about association of the variant with TTN-related conditions. The co-occurrence with other recessively inherited pathogenic variant(s) mentioned above (NEB c.24372_24375dup, p.Val8126fs; NEB, exon 55 deletion, p.Arg2478_Asp2512del), provide supporting evidence for a benign role due to an alternative molecular basis of disease (Scoto_2013). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 23443021). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and all submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
The Leu1172Ile variant in TTN has not been previously reported in individuals wi th cardiomyopathy, but has been identified in 1/8600 European American chromosom es by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). Com putational prediction tools and conservation analysis do not provide strong supp ort for or against an impact to the protein. Additional information is needed to fully assess the clinical significance of the Leu1172Ile variant. -
- -
Cardiovascular phenotype Uncertain:1
The p.L1126I variant (also known as c.3376C>A), located in coding exon 19 of the TTN gene, results from a C to A substitution at nucleotide position 3376. The leucine at codon 1126 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at